StockData
Vera Therapeutics, Inc. logo

Vera Therapeutics, Inc. (VERA) stock

VERANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 2/30
$26.20−0.77 (-2.86%)

Close on Nov 17, 2026Market cap $1.89BP/E –Yield –

Vera Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

No price to sales ratio figures for Vera Therapeutics

Vera Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Vera Therapeutics figures

See a number that looks wrong?